This week at Retraction Watch featured a look at the nuances of replication efforts, aka “the replication paradox,” as well as yet another story of fake peer reviews, this time at Hindawi. Here’s what was happening elsewhere:
One of Paolo Macchiarini’s co-authors on a 2011 Lancet paper describing an allegedly groundbreaking procedure to transplant an artificial trachea seeded with stem cells is objecting to a recent investigation that concluded Macchiarini had committed misconduct. Ola Hermanson, who studies neural stem cells at Karolinska Institutet, argued in a report dated June 29 that the … Continue reading Macchiarini co-author objects to investigation’s misconduct verdict
This week at Retraction Watch featured the retraction of a Cell paper by Harvard researchers and the retraction of a JCI study by NIH scientists. Here’s what was happening elsewhere:
Public health expert Stephen Leeder has been ousted as editor of Australia’s top medical journal after he questioned the decision to outsource the journal’s production and other tasks to publishing giant Elsevier. Leeder, emeritus professor at the University of Sydney, told the Medical Observer he was asked to leave when he and the journal’s publisher, … Continue reading Editor of Medical Journal of Australia fired after criticizing decision to outsource to Elsevier
The week at Retraction Watch featured the retraction of 11 papers by a controversial researcher in Italy, and a look at the controversy over lead in the water supply. Here’s what was happening elsewhere:
Surgeon Paolo Macchiarini, who is under investigation for allegedly downplaying dangers of an experimental surgery, has been cleared of some misconduct allegations by the Karolinska Institutet in Stockholm. Macchiarini, a thoracic surgeon, has made headlines for repairing damaged airways using tracheas from cadavers and even synthetic tracheas, both treated with the patients’ own stem cells to … Continue reading “Super-surgeon” Macchiarini not guilty of misconduct, per one Karolinska investigation
This week at Retraction Watch featured two Office of Research Integrity findings, and retractions in the Voinnet and Hanna cases. Here’s what was happening elsewhere:
As Retraction Watch readers know, public health officials are concerned about a U.S. measles outbreak. As The New York Times notes: The United States has already had more cases of measles in the first month of 2015 than the number that is typically diagnosed in a full year. This follows a year in which the number of … Continue reading Fraud’s long tail: Measles outbreak shows why it’s important to look downstream of retractions
On Friday, we reported on the retraction and republication of a paper in The Lancet. One of the paper’s authors, Yale’s Harlan Krumholz, took issue with how we characterized the reason for the retraction. We offered him a chance to write a guest post about the situation, which we are pleased to publish below. Please … Continue reading Retraction Watch “mischaracterized the reason for a retraction:” Harlan Krumholz responds to a post
Piero Anversa, a stem cell researcher at the Brigham & Women’s Hospital, and a colleague, Annarosa Leri, have sued Harvard over an investigation into their work that they claim has cost them millions in a forfeited sale of their company, and job offers. The team has had a paper in Circulation retracted, and a paper in … Continue reading Stem cell researchers sue Harvard, claiming faulty investigation lost them job offers